Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change

English version České info

Background:
Increased adiposity is linked with higher risk for cardiometabolic diseases. We aimed to determine to what extent elevated body mass index (BMI) within the normal weight range has causal effects on the detailed systemic metabolite profile in early adulthood.

Methods and Findings:
We used Mendelian randomization to estimate causal effects of BMI on 82 metabolic measures in 12,664 adolescents and young adults from four population-based cohorts in Finland (mean age 26 y, range 16–39 y; 51% women; mean ± standard deviation BMI 24±4 kg/m²). Circulating metabolites were quantified by high-throughput nuclear magnetic resonance metabolomics and biochemical assays. In cross-sectional analyses, elevated BMI was adversely associated with cardiometabolic risk markers throughout the systemic metabolite profile, including lipoprotein subclasses, fatty acid composition, amino acids, inflammatory markers, and various hormones (p<0.0005 for 68 measures). Metabolite associations with BMI were generally stronger for men than for women (median 136%, interquartile range 125%–183%). A gene score for predisposition to elevated BMI, composed of 32 established genetic correlates, was used as the instrument to assess causality. Causal effects of elevated BMI closely matched observational estimates (correspondence 87%±3%; R² = 0.89), suggesting causative influences of adiposity on the levels of numerous metabolites (p<0.0005 for 24 measures), including lipoprotein lipid subclasses and particle size, branched-chain and aromatic amino acids, and inflammation-related glycoprotein acetyls. Causal analyses of certain metabolites and potential sex differences warrant stronger statistical power. Metabolite changes associated with change in BMI during 6 y of follow-up were examined for 1,488 individuals. Change in BMI was accompanied by widespread metabolite changes, which had an association pattern similar to that of the cross-sectional observations, yet with greater metabolic effects (correspondence 160%±2%; R² = 0.92).

Conclusions:
Mendelian randomization indicates causal adverse effects of increased adiposity with multiple cardiometabolic risk markers across the metabolite profile in adolescents and young adults within the non-obese weight range. Consistent with the causal influences of adiposity, weight changes were paralleled by extensive metabolic changes, suggesting a broadly modifiable systemic metabolite profile in early adulthood.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change. PLoS Med 11(12): e32767. doi:10.1371/journal.pmed.1001765
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001765

Souhrn

Zdroje

1. NgM, FlemingT, RobinsonM, ThomsonB, GraetzN, et al. (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384: 766–781.

2. Prospective Studies Collaboration (2009) WhitlockG, LewingtonS, SherlikerP, ClarkeR, et al. (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083–1096.

3. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects) (2014) LuY, HajifathalianK, EzzatiM, WoodwardM, et al. (2014) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 383: 970–983.

4. LewisCE, McTigueKM, BurkeLE, PoirierP, EckelRH, et al. (2009) Mortality, health outcomes, and body mass index in the overweight range. Circulation 119: 3263–3271.

5. JensenMD, RyanDH, ApovianCM, ArdJD, ComuzzieAG, et al. (2014) 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation 129(25 Suppl 2): S102–S138.

6. Berrington de GonzalezA, HartgeP, CerhanJR, FlintAJ, HannanL, et al. (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363: 2211–2219.

7. FallT, HäggS, MägiR, PlonerA, FischerK, et al. (2013) The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med 10: e1001474.

8. NewgardCB, AnJ, BainJR, MuehlbauerMJ, StevensRD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311–326.

9. PietiläinenKH, RógT, Seppänen-LaaksoT, VirtueS, GopalacharyuluP, et al. (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9: e1000623.

10. LaferrèreB, ReillyD, AriasS, SwerdlowN, GorroochurnP, et al. (2011) Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 3: 80re2.

11. Davey SmithG, EbrahimS (2003) Mendelian randomization: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1–22.

12. LawlorDA, HarbordRM, SterneJAC, TimpsonN, Davey SmithG (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27: 1133–1163.

13. Davey SmithG, HemaniG (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Gen 23: R89–R98.

14. FreathyRM, TimpsonNJ, LawlorDA, PoutaA, Ben-ShlomoY, et al. (2008) Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 57: 1419–1426.

15. HolmesMV, LangeLA, PalmerT, LanktreeMB, NorthKE, et al. (2014) Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. Am J Hum Genet 94: 198–208.

16. TimpsonN, HarbordR, Davey SmithG, ZachoJ, Tybaerg-HansenA, et al. (2009) Does greater adiposity increase blood pressure and hypertension risk? Mendelian Randomization using FTO/MC4R genotype. Hypertension 54: 84–90.

17. RichmondRC, Davey SmithG, NessAR, den HoedM, McMahonG, et al. (2014) Assessing causality in the association between child adiposity and physical activity levels: a Mendelian randomization analysis. PLoS Med 11: e1001618.

18. TuomilehtoJ, LindströmJ, ErikssonJG, ValleTT, HämäläinenH, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343–1350.

19. PoirierP, GilesTD, BrayGA, HongY, SternJS, et al. (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 113: 898–918.

20. MoyerVA (2012) US Preventive Services Task Force (2012) Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157: 373–378.

21. KantomaaMT, StamatakisE, KankaanpääA, KaakinenM, RodriguezA, et al. (2013) Physical activity and obesity mediate the association between childhood motor function and adolescents' academic achievement. Proc Natl Acad Sci U S A 110: 1917–1922.

22. SabattiC, ServiceSK, HartikainenA, PoutaA, RipattiS, et al. (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41: 35–46.

23. RaitakariOT, JuonalaM, RönnemaaT, Keltikangas-JärvinenL, RäsänenL, et al. (2008) Cohort profile: the Cardiovascular Risk in Young Finns Study. Int J Epidemiol 37: 1220–1226.

24. VartiainenE, LaatikainenT, PeltonenM, JuoleviA, MännistöS, et al. (2010) Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 39: 504–518.

25. AuroK, JoensuuA, FischerK, KettunenJ, SaloP, et al. (2014) A metabolic view on menopause and ageing. Nat Commun 5: 4708.

26. WürtzP, MäkinenVP, SoininenP, KangasAJ, TukiainenT, et al. (2012) Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 61: 1372–1380.

27. WürtzP, TiainenM, MäkinenVP, KangasAJ, SoininenP, et al. (2012) Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care 35: 1749–1756.

28. SoininenP, KangasAJ, WürtzP, SunaT, Ala-KorpelaM (2014) Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet In press.

29. KettunenJ, TukiainenT, SarinAP, Ortega-AlonsoA, TikkanenE, et al. (2012) Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44: 269–276.

30. KujalaUM, MäkinenVP, HeinonenI, SoininenP, KangasAJ, et al. (2013) Long-term leisure-time physical activity and serum metabolome. Circulation 127: 340–348.

31. FischerK, KettunenJ, WürtzP, HallerT, HavulinnaAS, et al. (2014) Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med 1: e1001606.

32. SoininenP, KangasAJ, WürtzP, TukiainenT, TynkkynenT, et al. (2009) High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 134: 1781–1785.

33. InouyeM, KettunenJ, SoininenP, SilanderK, RipattiS, et al. (2010) Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 6: 441.

34. SpeliotesEK, WillerCJ, BerndtSI, MondaKL, ThorleifssonG, et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42: 937–948.

35. VoightBF, KangHM, DingJ, PalmerCD, SidoreC, et al. (2012) The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8: e1002793.

36. RobertsLD, GersztenRE (2013) Towards novel biomarkers of cardiometabolic diseases. Cell Metab 18: 43–50.

37. WangTJ, LarsonMG, VasanRS, ChengS, RheeEP, et al. (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448–453.

38. MagnussonM, LewisGD, EricsonU, Orho-MelanderM, HedbladB, et al. (2013) A diabetes-predictive amino acid score and future cardiovascular disease. Eur Heart J 34: 1982–1989.

39. DesprésJP, LemieuxI (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881–887.

40. TimpsonNJ, NordestgaardBG, HarbordRM, ZachoJ, FraylingTM, et al. (2011) C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 35: 300–308.

41. NordestgaardBG, PalmerTM, BennM, ZachoJ, Tybjaerg-HansenA, et al. (2012) The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 9: e1001212.

42. WilliamsPT, KraussRM, VranizanKM, WoodPD (1990) Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation 81: 1293–1304.

43. WeirJM, WongG, BarlowCK, GreeveMA, KowalczykA, et al. (2013) Plasma lipid profiling in a large population-based cohort. J Lipid Res 54: 2898–2908.

44. FlegalKM, KitBK, OrpanaH, GraubardBI (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309: 71–82.

45. Davey SmithG, SterneJA, FraserA, TyneliusP, LawlorDA, et al. (2009) The association between BMI and mortality using offspring BMI as an indicator of own BMI: large intergenerational mortality study. BMJ 339: b5043.